Delivery Order SPE2DB22D2206-SPE2DB24FFZ36
- Not listed
- This federal contract award, valued at $9,032.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of CIBINQO 100 MG TABLET, a pharmaceutical product, with a completion date of September 13, 2024. This is a Firm Fixed Price Delivery Order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded...
- This federal contract award, valued at $13,935.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a delivery order for the provision of CIBINQO 100 MG TABLET pharmaceutical products. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $73,657.37 firm fixed-price contract is for the supply of CIBINQO 100 MG TABLET UU 30S, a medical product. The contract has an ultimate completion date of April 21, 2023 and was awarded on April 20, 2023. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,511.02 firm fixed-price delivery order contract covers the supply of CIBINQO 100 MG TABLET UU 30S, a medical product, with a performance period extending through March 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award, valued at $3,400.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that provides for the delivery of CIBINQO 100 MG TABLET UU 30S, a pharmaceutical product, with a completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $5,357.65 to AmerisourceBergen Drug Corp for the supply of CIBINQO 100 mg tablets in quantities of 30 units. This firm fixed-price delivery order, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a non-competitive award under an existing contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,332.08 to AmerisourceBergen Drug Corp for the supply of CIBINQO 100 mg tablets (30-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- This federal contract award is for the delivery of Cibinqo 100 mg tablets to the Defense Logistics Agency (DLA). The $10,170.01 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 28, 2023. The contract has an ultimate completion date of December 29, 2023 and is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,470.94 firm fixed price contract is for the delivery of CIBINQO 50 MG TABLET UU 30S, a specialty pharmaceutical product. It has an ultimate completion date of April 17, 2023. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of CIBINQO 100 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,183.10 and an ultimate completion date of September 25, 2024. It was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 24, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFZ36Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of pharmaceutical products, including CIBINQO 100 MG TABLET. The contract is a Delivery Order with a Firm Fixed Price of $19,691.42 and an Ultimate Completion Date of March 8, 2024. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 3/7/24 |